Texas-Based TYBR Health Raises $30M in Series A Funding Round
Jul 22, 2026 | By Devin Jacobs

TYBR Health, a Houston, TX-based company developing clinical improvements in post-operative tendon mobility, has raised $30 million in a Series A funding round led by Vensana Capital and Mutual Capital Partners.
SUMMARY
- TYBR Health raised $30 million in a Series A funding round led by Vensana Capital and Mutual Capital Partners.
- TYBR Health is a medical technology company that develops products to improve healing and recovery after orthopedic surgery.
- The funding will support business expansion, product development, and wider adoption of its FDA-cleared B3 GEL® System.
The round also saw participation from Neovate Capital Partners and existing investors.
The company will use the funding to expand its operations and accelerate product development.
Read More:AI Startup Uniti Raises $12M in Series A Funding Round
RECOMMENDED FOR YOU
Paramount to Acquire Warner Bros in $111B Deal as Netflix Backs Out
Devin Jacobs
Feb 28, 2026
Orthopedic surgery can successfully repair damaged bones, muscles, tendons, and ligaments, but recovery depends on how the body heals after the operation. Healing affects pain, movement, scarring, and how well patients regain normal function, yet doctors have had limited ways to improve this process.
TYBR Health focuses on this important recovery period. Its FDA-cleared B3 GEL® System is a flowable hydrogel designed to protect tendons, ligaments, muscles, and surrounding soft tissue, helping them heal more effectively after surgery.
"B3 GEL® adheres where it's applied, conforms to the native anatomy, and forms a protective barrier through the healing window," said Greg Banker, Partner at Vensana Capital. "TYBR has shown real commercial traction early and built a strong team, and we're glad to back them in this next phase."
"TYBR Health is addressing a gap surgeons have lived with for a long time, with a product that fits the way they already work," said Liz Todia Zambory, Principal at Mutual Capital Partners. "We're excited to co-lead this round and support the company's growth."
Surgeons are exceptionally good at the structural repair, but the biology that follows is what determines how it heals. That part of the equation has gone largely unaddressed," said Tim Keane, PhD, co-founder and CEO of TYBR Health. "We built TYBR Health around a simple principle: managing the healing environment should complement good surgical technique and contribute to better recovery for patients."
"There's a shift underway across surgical specialties, from focusing almost entirely on the mechanical repair to also weighing the biological conditions that repair needs to succeed," Keane added. "This financing lets us reach more surgeons and generate the clinical evidence to move that shift forward."
About TYBR Health
Founded in 2020 by Tim Keane and P. Alex Smith, TYBR Health is a Houston, Texas-based medical technology company focused on improving healing after surgery. The company develops extracellular matrix products that help protect healing tissues and give surgeons better tools to support recovery after surgical procedures.
Read More:Karoo Health Bags $16.2M in Series A Funding Round








